title: Influence of marginal donors on liver preservation injury.
abstract: OBJECTIVE
  The purpose of this study was to assess the accumulated effects of marginal donor quality factors on liver preservation injury (LPI).
  
  
  METHODS
  The most recent 400 consecutive liver transplantations at our institution were reviewed. Marginal liver donor criteria included the following: older than 60 years, an intensive care unit stay under ventilatory support for more than 4 days, a cold ischemia time more than 14 hr, high inotropic drug use, prolonged hypotensive episodes for more than 1 hr and less than 60 mm Hg, a peak serum sodium more than 155 mEq/L, and high levels of bilirubin, alanine transferase, or amino transferase. The type of steatosis (macrovesicular or microvesicular) was quantified in four categories: no steatosis, mild (<30%), moderate (30-60%), and severe (> 60%). LPI was stratified histologically in four levels: no damage, mild, moderate, and severe injury. These variables were included in a logistic regression analysis for prediction of the probability of the appearance of LPI.
  
  
  RESULTS
  Five variables showed an independent influence on LPI: high inotropic drug use (odds ratio [OR]=1.56), donor age (OR=1.017 per year), moderate to severe macrovesicular steatosis (OR=3.63), cold ischemia time (OR=1,109 per hour), and prolonged stay in an intensive care unit (OR=1.79). Severe LPI was present in 32.7% of the grafts from donors without any factor of the model; in 46.8% from donors with one factor (P =0.09); in 66.2% from donors with two factors (P =0.006); and in 78.3% from donors with at last three factors (P =0.002) (global P=0.0001; chi2 =21.8).
  
  
  CONCLUSIONS
  LPI can be potentially predicted based on donor and graft conditions. Accumulation of factors is correlated with an increased effect on LPI.
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D006801:Humans; D008099:Liver / Q000502:physiology*; D016031:Liver Transplantation; D008875:Middle Aged; D015999:Multivariate Analysis; D009926:Organ Preservation / Q000009:adverse effects*; D013997:Time Factors; D014019:Tissue Donors